Organon & Co Stock - Thursday chart snapshot and technical picture
18.06.2026 - 19:12:05 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:05 UTC. Details in the imprint.
Organon & Co (US68622V1061) is trading without a fresh corporate headline on Thursday, so the focus turns to the stock’s chart setup and current valuation range. The shares continue to move near the lower end of their 12-month band on the New York Stock Exchange.
All news and key data on Organon & Co stock
Price data, fundamentals and future headlines for Organon & Co stock are bundled in the ad hoc news topic hub and on the company’s own investor-relations pages.
What recent prices show
Organon & Co shares most recently closed at about $13.43 on the NYSE, implying a market capitalization near $3.5 billion based on publicly available quote data. That puts the stock well below its levels seen shortly after the 2021 spin-off from Merck.
Data from trading portals indicate that the stock’s trailing price-earnings ratio is in the low-teens, around 14 times earnings, which is consistent with a cautious valuation for a mature pharmaceutical portfolio. Day-to-day moves have been relatively muted in recent sessions.
Thursday’s chart and technicals
On Thursday, Organon & Co shares are changing hands in a narrow range around the mid-teens, with intraday volatility modest compared with the broader Standard & Poor's 500 index. Trading volumes remain moderate, suggesting no major repositioning by investors.
From a descriptive perspective, the stock is hovering near the lower portion of its 52-week trading corridor, which highlights a subdued sentiment backdrop but also a period of consolidation after earlier declines. Technical traders are watching whether support in this area will continue to hold.
How the company makes money
Organon & Co generates most of its revenue from women’s health, biosimilars and legacy established brands, including well-known contraceptive and fertility products, as outlined in its corporate materials on the investor-relations website. The portfolio is global, with a strong footprint outside the United States.
Where the stock trades today
The shares of Organon & Co (US68622V1061) trade on the New York Stock Exchange at $13.43 as of 06/17/2026, 16:00 ET.
Organon & Co stock at a glance
- Company: Organon & Co Inc.
- ISIN: US68622V1061
- WKN: A3CSKB
- Ticker: OGN
- Venue: NYSE
- Price (as of 06/17/2026, 16:00 ET): 13.43 USD
- Market cap: 3.52 billion USD (as of 06/17/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: none of the major headline indices such as the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
